TMCO5B
Transmembrane and coiled-coil domain-containing protein 5B
Also known as: TMC5B_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for TMCO5B in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
307 residues, UniProt reviewed canonical sequence.
>A8MYB1|TMCO5B
1 MEDVGQNPLD DVKNIFFASS LEAVKQNLDC LNSDLEKDLQ KLDMENQVLL RKIKEKEETI
61 SSLERKLALS LEEAKEEEEL NYVIDEQEES LRELELETAK LEKSNAILSR NVVEVQKKIS
121 GLFTNIGLEE ETTKQILEEM KARLQKSTES CAKQEEELAK IESDYQSVSD LCKDQVYYIK
181 KYQEVLRKMK EEKETLLLEK QISKAQDDSS QTVKPGSILA DTTQRNMERT TIKKQERRCW
241 YKYFQYLTFM VLVFIRLLAY VIFHLQYINP DLLVDVLPLV LSRGTLESLR KVSHPFLTLA
301 VEEALPHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMCO5B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.5
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMCO5B as an antibody target. Whether an autoantibody or antibody against TMCO5B could matter depends on whether native TMCO5B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMCO5B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMCO5B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...